LIVER INTERNATIONAL
Scope & Guideline
Advancing hepatology through cutting-edge research.
Introduction
Aims and Scopes
- Metabolic Liver Disorders:
The journal consistently explores metabolic dysfunction-associated liver diseases (MAFLD) and its implications, emphasizing the relationship between metabolic syndrome, liver health, and overall patient outcomes. - Viral Hepatitis Research:
A significant portion of the publications focuses on hepatitis B and C, including new treatment strategies, epidemiology, and the challenges of achieving viral eradication and elimination. - Innovative Diagnostic Techniques:
Liver International highlights advancements in diagnostic methodologies, including non-invasive imaging and biomarkers, to assess liver disease progression and treatment efficacy. - Liver Cancer Studies:
Research on hepatocellular carcinoma (HCC) is a major focus, encompassing topics from early diagnosis and prognostic factors to treatment outcomes and novel therapeutic strategies. - Clinical Management and Guidelines:
The journal provides insights into clinical practices, treatment guidelines, and the integration of multidisciplinary approaches to improve liver disease management. - Socioeconomic and Public Health Impacts:
Articles often address the socioeconomic factors affecting liver disease prevalence and treatment access, highlighting disparities among different populations. - Drug-Induced Liver Injury:
The journal discusses the mechanisms and implications of drug-induced liver injury, providing insights into prevention, diagnosis, and management. - Emerging Therapies and Clinical Trials:
Research on new therapeutic agents and clinical trials is a recurring theme, focusing on innovative treatments for various liver diseases, including antiviral therapies and immunotherapies.
Trending and Emerging
- Metabolic Dysfunction and Liver Disease:
There is a significant increase in research focused on metabolic dysfunction-associated fatty liver disease (MAFLD) and its relationship with obesity, diabetes, and cardiovascular health. - Artificial Intelligence and Machine Learning Applications:
Emerging studies are increasingly applying AI and machine learning to predict liver disease outcomes, enhance diagnostic accuracy, and optimize treatment strategies. - Health Disparities and Social Determinants:
A growing body of work is examining the impact of socioeconomic factors on liver disease prevalence and treatment access, emphasizing the need for equitable healthcare solutions. - Long-term Outcomes Following Viral Hepatitis Treatment:
Increasing attention is being paid to the long-term outcomes of patients treated for chronic hepatitis B and C, including the risk of liver cancer and reinfection. - Integration of Gut Microbiome Research:
Research exploring the gut-liver axis and its implications for liver disease is on the rise, focusing on how gut health influences liver conditions. - Immunotherapy in Liver Cancer:
There is a notable trend toward investigating immunotherapeutic approaches for treating hepatocellular carcinoma, reflecting advancements in cancer treatment. - Non-invasive Monitoring Techniques:
The development and validation of non-invasive tools for assessing liver stiffness and fibrosis are gaining momentum, providing alternatives to traditional biopsy.
Declining or Waning
- Traditional Liver Biopsy Techniques:
There is a noticeable decline in studies focused on conventional liver biopsy techniques as non-invasive methods gain favor for diagnosing liver diseases. - Acute Liver Failure Studies:
Research specifically targeting acute liver failure has waned, possibly due to the increasing focus on chronic liver diseases and their long-term management. - Alcohol-Related Liver Disease Studies:
The frequency of publications solely addressing alcohol-related liver disease has decreased, which may reflect a broader shift toward understanding metabolic and multifactorial liver diseases. - Hepatitis E Research:
Interest in hepatitis E research appears to be declining, with fewer studies published in recent years as other liver diseases gain more attention.
Similar Journals
Hepatology Forum
Fostering collaboration in the fight against liver disorders.Hepatology Forum is an esteemed journal dedicated to disseminating cutting-edge research and insights in the fields of gastroenterology and hepatology. Published by KARE PUBL in Turkey, this journal serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to advance their knowledge and practices related to liver diseases and gastrointestinal disorders. With an ISSN of 1307-5888 and an E-ISSN of 2757-7392, it features peer-reviewed articles that encompass a wide range of topics from basic research to clinical applications. Although categorized in the Q3 quartile for both gastroenterology and hepatology in 2023, Hepatology Forum continues to show significant potential for growth and impact, as evidenced by its Scopus rankings. Through its commitment to open scientific exchange, the journal not only facilitates the sharing of innovative methodologies and findings but also fosters networking among professionals in the field. As it converges through the years from 2020 to 2024, Hepatology Forum remains an important resource for the advancement of liver health and diseases, appealing to both established experts and emerging scholars alike.
Canadian Journal of Gastroenterology and Hepatology
Fostering Collaboration in Gastrointestinal and Liver StudiesCanadian Journal of Gastroenterology and Hepatology, published by HINDAWI LTD, serves as a vital resource in the fields of gastroenterology and hepatology. Since its inception in 1987, this open-access journal has made significant contributions to advancing research and clinical practice through its comprehensive coverage of topics ranging from liver diseases to gastrointestinal disorders. With an impressive Q2 ranking in Gastroenterology and a Q3 ranking in Hepatology as of 2023, the journal has established itself as an influential platform for researchers and healthcare professionals seeking to disseminate and acquire knowledge. The journal is based in Egypt, with its operational headquarters located in London, England. Notably, it holds a respectable standing in Scopus rankings, placed at Rank #64 in Gastroenterology and Rank #34 in Hepatology, reflecting its impact and relevance in the medical community. With a commitment to quality and accessibility, the Canadian Journal of Gastroenterology and Hepatology continues to foster innovation and collaboration among its readers.
Liver Cancer
Unveiling breakthroughs in hepatology and oncology.Liver Cancer is a premier, peer-reviewed journal dedicated to the comprehensive study and advancement of knowledge surrounding liver neoplasms. Published by KARGER and headquartered in Switzerland, this journal has been an open-access platform since 2012, providing researchers with invaluable insights into the rapidly evolving field of hepatology and oncology. With an impressive impact factor that places it in the Q1 category for both Hepatology and Oncology in 2023, Liver Cancer stands out as a high-impact conduit for groundbreaking research, ranking #19 out of 404 in Medicine _ Oncology and #6 out of 82 in Medicine _ Hepatology according to Scopus. Researchers, practitioners, and students are encouraged to engage with the journal's content, which encompasses clinical studies, basic research, and reviews that contribute significantly to understanding liver cancer dynamics, diagnosis, and treatment strategies. This journal not only facilitates the dissemination of knowledge but also fosters collaboration in a well-established and impactful global scientific community.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Innovative insights into digestive and liver health.Welcome to the JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, an esteemed publication in the field of gastroenterology and hepatology, proudly published by WILEY. Established in 1986, this journal serves as a crucial platform for researchers, healthcare professionals, and students, presenting groundbreaking research and comprehensive reviews that drive advances in understanding and treating gastrointestinal and liver diseases. With a strong reputation evidenced by its Q1 ranking in gastroenterology and Q2 ranking in hepatology, this journal ranks impressively in the Scopus metrics - positioned at #22 out of 167 in gastroenterology and #21 out of 82 in hepatology, reflecting its contribution to scholarly excellence. Although it does not offer open access options, the journal’s rich archive and diverse topics make it indispensable for those dedicated to improving patient outcomes in these critical areas of medicine. Whether you are a seasoned researcher or an aspiring medical professional, engaging with this journal will keep you at the forefront of the latest developments and emerging trends in gastroenterology and hepatology research.
JHEP Reports
Advancing healthcare knowledge through open access.JHEP Reports, published by ELSEVIER, stands at the forefront of scholarly communication in the fields of Gastroenterology, Hepatology, Immunology and Allergy, and Internal Medicine. As an Open Access journal since 2019, it provides a platform for the dissemination of high-quality research findings, making vital information readily accessible to a global audience. With a commendable impact characterized by a Q1 category ranking across four medical disciplines in 2023, JHEP Reports demonstrates its significance and influence, reflected in its impressive Scopus ranks—#11 in Gastroenterology and #14 in Internal Medicine, amongst others. This esteemed journal not only plays a critical role in advancing knowledge but also fosters collaboration among researchers, practitioners, and students keen on exploring innovations and breakthroughs in health sciences. At RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, JHEP Reports is committed to bridging the gap between research and application, ushering in a new era of informed and effective healthcare solutions.
Canadian Liver Journal
Driving Excellence in Hepatology Research.Canadian Liver Journal, published by University of Toronto Press Inc., offers a dedicated platform for the dissemination of cutting-edge research in the field of Hepatology. With an E-ISSN of 2561-4444, this journal plays a pivotal role in advancing knowledge related to liver diseases and therapies, currently ranked in the 3rd quartile (Q3) for the 2023 category in Hepatology—a reflection of its growing influence in the biomedical research community. The journal, which has been in circulation since 2018 and sets its sights on contributing valuable insights until 2024, aims to engage researchers, clinicians, and students alike by providing a rigorous peer-reviewed environment for sharing findings, case studies, and reviews pertinent to liver health. Through its commitment to excellence and scholarly impact, the Canadian Liver Journal serves as an essential resource for those dedicated to combating liver diseases and enhancing patient care.
Clinics in Liver Disease
Connecting researchers and clinicians for liver health advancements.Clinics in Liver Disease is an esteemed peer-reviewed journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of hepatology. Established in 1997 and covering a broad range of topics within liver disease research, this journal serves as a vital resource for researchers, clinicians, and students engaged in the study of liver health and diseases. With a commendable impact factor placing it within the Q2 category in Hepatology and ranking #32 out of 82 in the Scopus classifications, it consistently disseminates high-quality research and clinical insights. The journal’s commitment to promoting understanding and management of liver diseases is reflected in its rigorous editorial standards and comprehensive review processes. Although not an open-access publication, Clinics in Liver Disease offers subscription options that ensure accessibility to up-to-date research and reviews critical for both academic and clinical success.
HEPATOLOGY RESEARCH
Innovative insights for a healthier liver and brighter future.Hepatology Research, ISSN 1386-6346 and E-ISSN 1872-034X, is a premier academic journal published by Wiley that serves the dynamic fields of Hepatology and Infectious Diseases. With an impressive 2023 impact factor and ranked Q2 in Hepatology and Q1 in Infectious Diseases, this journal stands out as a vital resource for researchers, professionals, and students. Covering a broad spectrum of topics related to liver health, the journal aims to disseminate cutting-edge research and insights from the converged years of 1997 to 2024. As an open-access platform, it fosters the global sharing of knowledge, providing valuable access to pioneering studies that address pressing issues in liver disease and its associated infections. Based in the United Kingdom, at 111 River St, Hoboken, NJ, Hepatology Research is pivotal for advancing scientific understanding and improving patient outcomes worldwide.
Clinical and Molecular Hepatology
Empowering global knowledge exchange in liver research.Clinical and Molecular Hepatology, published by the Korean Association for the Study of Liver, stands at the forefront of hepatology, offering a significant platform for research and innovation in liver diseases. Established in 1995 as an open access journal, it aims to disseminate high-quality research that spans the fields of hepatology, molecular biology, and medicine. With an impressive impact factor ranking it in the Q1 category for 2023 in both Hepatology and Molecular Biology, the journal facilitates a rich exchange of knowledge among professionals, researchers, and students globally. With its dedicated coverage from 2012 to 2024 and exceptional Scopus rankings placing it within the top 10% of journals in its field, Clinical and Molecular Hepatology is an indispensable resource for advancing the understanding and treatment of liver conditions. Located in Seoul, South Korea, the journal emphasizes rigorous peer review and is committed to enhancing clinical practice and molecular research, making it an ideal venue for groundbreaking studies in liver health.
Saudi Journal of Gastroenterology
Fostering innovation in clinical gastroenterology.The Saudi Journal of Gastroenterology is a premier platform dedicated to advancing research and clinical practice in the field of gastroenterology. Published by Wolters Kluwer Medknow Publications, this open-access journal has been serving the academic community since 1995 from its base in India. With an ISSN of 1319-3767 and an E-ISSN of 1998-4049, the journal allows unrestricted access to a wealth of knowledge, fostering an environment where researchers, professionals, and students can engage with cutting-edge studies. As of 2023, it is categorized in the Q3 quartile within gastroenterology, ranking #74 out of 167 in Scopus, which places it within the 55th percentile of its field. The journal aims to disseminate significant findings, clinical trials, and innovative theories that shape the understanding of gastrointestinal disorders and practices. With a commitment to quality and relevance, the Saudi Journal of Gastroenterology is pivotal for anyone seeking to enhance their knowledge and expertise in this vital area of medicine.